Novartis Pharma AG

Where the EU money came from

Funding by EU programme. Amounts are Novartis Pharma AG's own share of each project, not the project's full budget.

Projects

115 EU-funded projects, newest first. Novartis Pharma AG led 8 of them as coordinator. Each links to the official record.

• PFAROSPartner

  Driving Sustainable Innovation to Minimise PFAS in European Healthcare

  Horizon Europe · 2026–2031 · Project on CORDIS ↗
• ANA-KINAssociated partner

  Advancing Novel Approaches in Kinase Interface Networks

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• WANECAM 3Partner

  SINGLE DOSE CURE OF FALCIPARUM MALARIA USING NEXT GENERATION COMBINATIONS

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €38ktheir share
• FORTIFYPartner

  FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• CitiesAtHeartPartner

  Cities@Heart: City-based Strategies for improving Cardiovascular Health in Europe

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• AF-B-STEPPartner

  Quantifying Atrial Fibrillation Burden to inform Screening, Treatment, and hEalth Policy

  Horizon Europe · 2026–2029 · Project on CORDIS ↗
• PROBEPartner

  Patient Relevant Osteoarthritis endpoints using Big data Evaluation

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• UNIFIEDPartner

  Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• BRIDGEPartner

  Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

  Horizon Europe · 2025–2028 · Project on CORDIS ↗
• LateFunAssociated partner

  Late-stage photocatalytic functionalization of alkenes and 1,3-dienes

  Horizon Europe · 2025–2027 · Project on CORDIS ↗
• Chiral-BetaAssociated partner

  Asymmetric carbyne catalytic transfer to streamline synthesis of chiral β-amino carbonyls

  Horizon Europe · 2025–2026 · Project on CORDIS ↗
• RealiseDPartner

  Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases

  Horizon Europe · 2025–2029 · Project on CORDIS ↗
• READIPartner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• Project-COMFORTPartner

  Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• AutoPiXPartner

  IMAGING FOR PATIENT BENEFIT IN ARTHRITIS

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• NHPigPartner

  Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models

  Horizon Europe · 2024–2029 · Project on CORDIS ↗
• VICT3RPartner

  Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• INVENTSAssociated partner

  Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs

  Horizon Europe · 2024–2028 · Project on CORDIS ↗
• IMPACTIVEAssociated partner

  Innovative Mechanochemical Processes to synthesize green ACTIVE pharmaceutical ingredients.

  Horizon Europe · 2022–2026 · Project on CORDIS ↗
• MetRaZymesAssociated partner

  Metal-containing Radical Enzymes

  Horizon Europe · 2022–2026 · Project on CORDIS ↗
• EPNDPartner

  European platform for neurodegenerative disorders

  Horizon 2020 · 2021–2026 · Project on CORDIS ↗
• SCREEN4CAREPartner

  Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies

  Horizon 2020 · 2021–2026 · Project on CORDIS ↗
• HIPPOCRATESPartner

  Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗
• BIGPICTUREPartner

  Central Repository for Digital Pathology

  Horizon 2020 · 2021–2027 · Project on CORDIS ↗
• Gravitate-HealthPartner

  Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• ARDATPartner

  Accelerating Research & Development for Advanced Therapies

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• H2OPartner

  H2O Health Outcomes Observatory

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• HARMONY PLUSPartner

  HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

  Horizon 2020 · 2020–2024 · Project on CORDIS ↗
• PREMIERPartner

  Prioritisation and Risk Evaluation of Medicines in the EnviRonment

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• CHAIRPartner

  C-H Activation for Industrial Renewal

  Horizon 2020 · 2020–2024 · Project on CORDIS ↗
• INNODIA HARVESTPartner

  Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

  Horizon 2020 · 2020–2024 · Project on CORDIS ↗
• CAREPartner

  Corona Accelerated R&D in Europe

  Horizon 2020 · 2020–2025 · Project on CORDIS ↗
• PharmaLedgerPartner

  PharmaLedger

  Horizon 2020 · 2020–2022 · Project on CORDIS ↗
• ImmUniversePartner

  Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗
• imSAVARPartner

  Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• EU-PEARLPartner

  EU Patient- cEntric clinicAl tRial pLatform

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗
• Immune-ImagePartner

  Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

  Horizon 2020 · 2019–2027 · Project on CORDIS ↗
• 3TRPartner

  Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

  Horizon 2020 · 2019–2028 · Project on CORDIS ↗
• Trials@HomePartner

  Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

  Horizon 2020 · 2019–2025 · Project on CORDIS ↗
• MELLODDYPartner

  MachinE Learning Ledger Orchestration for Drug DiscoverY

  Horizon 2020 · 2019–2022 · Project on CORDIS ↗

Showing the 80 most recent of 115 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Pfizer LimitedUnited Kingdom · 55 shared projects
• Janssen Pharmaceutica NVBelgium · 54 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 51 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 47 shared projects
• Sanofi-Aventis Recherche & DeveloppementFrance · 42 shared projects
• Astrazeneca ABSweden · 41 shared projects
• Eli Lilly and Company LtdUnited Kingdom · 39 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 39 shared projects
• Novo Nordisk A/SDenmark · 35 shared projects
• Bayer AktiengesellschaftGermany · 33 shared projects
• Ucb BiopharmaBelgium · 31 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 28 shared projects
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 26 shared projects
• Merck Kommanditgesellschaft Auf AktienGermany · 25 shared projects
• Katholieke Universiteit LeuvenBelgium · 24 shared projects
• Karolinska InstitutetSweden · 23 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• HIV
• RNA
• adverse drug reactions
• alzheimer
• animal and dairy science
• antibiotics
• arteriosclerosis
• artificial intelligence
• asthma
• autoimmune diseases
• bacteriology
• big data
• biochemistry
• biomolecules